Translation of targeted oncolytic virotherapeutics ... [Mol Ther. 2008] - PubMed

loading

Review Gene therapy progress and prospects cancer: oncolytic viruses. [Gene Ther. 2008]
Review Gene therapy progress and prospects cancer: oncolytic viruses.
Liu TC, Kirn D. Gene Ther. 2008 Jun; 15(12):877-84. Epub 2008 Apr 17.
Review Development of targeted oncolytic virotherapeutics through translational research. [Expert Opin Biol Ther. 2008]
Review Development of targeted oncolytic virotherapeutics through translational research.
Liu TC, Hwang TH, Bell JC, Kirn DH. Expert Opin Biol Ther. 2008 Sep; 8(9):1381-91.
Review Chapter four--Design of improved oncolytic adenoviruses. [Adv Cancer Res. 2012]
Review Chapter four--Design of improved oncolytic adenoviruses.
Alemany R. Adv Cancer Res. 2012; 115:93-114.
Review Strategy of Cancer Targeting Gene-Viro-Therapy (CTGVT) a trend in both cancer gene therapy and cancer virotherapy. [Curr Pharm Biotechnol. 2012]
Review Strategy of Cancer Targeting Gene-Viro-Therapy (CTGVT) a trend in both cancer gene therapy and cancer virotherapy.
Liu XY, Li HG, Zhang KJ, Gu JF. Curr Pharm Biotechnol. 2012 Jul; 13(9):1761-7.
Oncolytic viruses move forward in clinical trials. [J Natl Cancer Inst. 2010]
Oncolytic viruses move forward in clinical trials.
Rowan K. J Natl Cancer Inst. 2010 May 5; 102(9):590-5. Epub 2010 Apr 26.

Review Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates. [Cancer J. 2012]
Review Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates.
Wollmann G, Ozduman K, van den Pol AN. Cancer J. 2012 Jan-Feb; 18(1):69-81.
Adenovirus i-leader truncation bioselected against cancer-associated fibroblasts to overcome tumor stromal barriers. [Mol Ther. 2012]
Adenovirus i-leader truncation bioselected against cancer-associated fibroblasts to overcome tumor stromal barriers.
Puig-Saus C, Gros A, Alemany R, Cascalló M. Mol Ther. 2012 Jan; 20(1):54-62. Epub 2011 Aug 23.
Review Harnessing synthetic lethal interactions in anticancer drug discovery. [Nat Rev Drug Discov. 2011]
Review Harnessing synthetic lethal interactions in anticancer drug discovery.
Chan DA, Giaccia AJ. Nat Rev Drug Discov. 2011 May; 10(5):351-64.

Translation of targeted oncolytic virotherapeutics from the lab into the clinic,...
Translation of targeted oncolytic virotherapeutics from the lab into the clinic, and back again: a high-value iterative loop.
Mol Ther. 2008 Jun ;16(6):1006-8. doi: 10.1038/mt.2008.70.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed